Evteev Sergei, Ivanenkov Yan, Semenov Ivan, Malkov Maxim, Mazaleva Olga, Bodunov Artem, Bezrukov Dmitry, Sidorenko Denis, Terentiev Victor, Malyshev Alex, Zagribelnyy Bogdan, Korzhenevskaya Anastasia, Aliper Alex, Zhavoronkov Alex
Insilico Medicine Hong Kong Ltd., Hong Kong, Hong Kong SAR, China.
Insilico Medicine AI Limited, Abu Dhabi, United Arab Emirates.
Front Chem. 2024 Apr 3;12:1382512. doi: 10.3389/fchem.2024.1382512. eCollection 2024.
The significance of automated drug design using virtual generative models has steadily grown in recent years. While deep learning-driven solutions have received growing attention, only a few modern AI-assisted generative chemistry platforms have demonstrated the ability to produce valuable structures. At the same time, virtual fragment-based drug design, which was previously less popular due to the high computational costs, has become more attractive with the development of new chemoinformatic techniques and powerful computing technologies. We developed Quantum-assisted Fragment-based Automated Structure Generator (QFASG), a fully automated algorithm designed to construct ligands for a target protein using a library of molecular fragments. QFASG was applied to generating new structures of CAMKK2 and ATM inhibitors. New low-micromolar inhibitors of CAMKK2 and ATM were designed using the algorithm. These findings highlight the algorithm's potential in designing primary hits for further optimization and showcase the capabilities of QFASG as an effective tool in this field.
近年来,使用虚拟生成模型进行自动化药物设计的重要性稳步增长。虽然深度学习驱动的解决方案受到了越来越多的关注,但只有少数现代人工智能辅助的生成化学平台展示了生成有价值结构的能力。与此同时,基于虚拟片段的药物设计,由于之前计算成本高而不太受欢迎,随着新的化学信息学技术和强大计算技术的发展,变得更具吸引力。我们开发了量子辅助片段自动结构生成器(QFASG),这是一种全自动算法,旨在使用分子片段库为目标蛋白构建配体。QFASG被应用于生成CAMKK2和ATM抑制剂的新结构。使用该算法设计了新的低微摩尔浓度的CAMKK2和ATM抑制剂。这些发现突出了该算法在设计初始命中物以进行进一步优化方面的潜力,并展示了QFASG作为该领域有效工具的能力。